|
In the emerging era of personalized medicine, every patient
will be unique and treated differently. Many drugs, for example,
will be prescribed not only on the basis of the patient’s
disease, but also on the basis of the patient’s genotype and
phenotype. As drug delivery becomes more highly targeted to the
specific sites of disease, therapies will increasingly rely on
new medical imaging techniques. In providing doctors with the
much larger data sets needed for personalized medicine,
biomedical engineering will play an ever-increasing role.
In all biomedical solutions, biocompatibility of the
physical principles, materials and techniques employed
becomes a critical issue. Successfully engineering these
solutions therefore requires a thorough understanding
of the interaction between biological systems and engineering
materials, adding to the design equation of finding materials
with right physical, electrical and thermal properties.
Miniaturization is also a major driver, both for in-vivo
applications (for example, intelligent implants) and in
areas such as the development of near-patient in-vitro
diagnostic testing. Achieving it requires extensive expertise
in System-in-Package (SiP) design, simulation and manufacturing.
In addition, few biomedical applications exist as point
solutions. They are nearly always embedded in infrastructures
that also involve telemetry, patient monitoring and medical
IT.
With its broad portfolio of enabling technologies, System-in-Package
design skills, process technology expertise and proven
performance in biomedical device development, Philips
Applied Technologies is a partner of choice in this important
field.
|
news loading
